Abstract
and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23:8469-8476, 2005 27. Leach MO, Boggis CR, Dixon AK, et al: Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: A prospective multicentre cohort study (MARIBS). Lancet 365: 1769-1778, 2005 28. Trecate G, Vergnaghi D, Bergonzi S, et al: Breast MRI screening in patients with increased familial and/or genetic risk for breast cancer: A preliminary experience. Tumori 89:125-131, 2003 29. Warner E, Hill K, Causer P, et al: Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. J Clin Oncol 29:1664-1669, 2011 30. Foulkes WD, Reis-Filho JS, Narod SA: Tumor size and survival in breast cancer: A reappraisal. Nat Rev Clin Oncol 7:348-353, 2010 31. Hagen AI, Tretli S, Maehle L, et al: Survival in Norwegian BRCA1 mutation carriers with breast cancer. Hered Cancer Clin Pract 14;7, 2009 32. Foulkes WD, Grainge MJ, Rakha EA, et al: Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status. Breast Cancer Res Treat 111:199-204, 2009 33. Robson ME, Chappuis PO, Satagopan J, et al: A combined analysis of outcome following breast cancer: Differences in survival based on BRCA1/ BRCA2 mutation status and administration of adjuvant treatment. Breast Cancer Res 6:R8-R17, 2004 34. Moller P, Borg A, Evans DG, et al: Survival in prospectively ascertained familial breast cancer: Analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy. Int J Cancer 101:555-559, 2002 35. Maurice A, Evans DG, Affen J, et al: Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: Further evidence of benefit. Int J Cancer [epub ahead of print on August 23, 2011] 36. Evans DG, Gaarenstroom KN, Stirling D, et al: Screening for familial ovarian cancer: Poor survival of BRCA1/2 related cancers. J Med Genet 46:593-597, 2009
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
